Overexpression of heme oxygenase (HO)-1 renders jurkat t cells resistant to fas-mediated apoptosis: Involvement of iron released by HO-1

Free Radical Biology and Medicine

Volumn 36, Issue 7, 2004, Pages 858-871

  Choi, Byung Min ^a   Pae, Hyun Ock ^a   Jeong, Young Ran ^a   Oh, Gi Su ^b   Jun, Chang Duk ^a   Kim, Bok Ryang ^b   Kim, Young Myeong ^c   Chung, Hun Taeg ^a,b  

^a Wonkwang University School of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Apoptosis; Free radicals; Heme oxygenase 1; Iron; NF B; T cell

Indexed keywords

CD4 ANTIGEN; DEFEROXAMINE; FAS ANTIBODY; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; HEME OXYGENASE 1; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGOMER; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GENE INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IRON DEPLETION; IRON TRANSPORT; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANTIGENS, CD95; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CD4-POSITIVE T-LYMPHOCYTES; DNA, COMPLEMENTARY; FLOW CYTOMETRY; GENES, BCL-2; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; IMMUNOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; IRON; JURKAT CELLS; MEMBRANE PROTEINS; NF-KAPPA B; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; PROTOPORPHYRINS; REACTIVE OXYGEN SPECIES; TRANSFECTION;

EID: 1542395639     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.01.004     Document Type: Article

References (58)

1. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with widespread implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
2. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;2239-2244.
3. Marsden V.S., Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 21:2003;71-105.
4. Lenardo M., Chan F.K.M., Hornung F., McFarland H., Siegel R., Wang J., Zheng L. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:1999;221-253.
5. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
6. Krammer P.H. CD95's deadly mission in the immune system. Nature. 407:2000;789-795.
7. Opferman J.T., Korsmeyer S.J. Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4:2003;410-415.
8. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 15:2001;2922-2933.
9. Scaffidi C., Schmitz I., Zha J., Korsmeyer S.J., Krammer P.H., Peter M.E. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274:1999;22532-22538.
10. Sun X.M., Bratton S.B., Butterworth M., MacFarlane M., Cohen G.M. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J. Biol. Chem. 277:2002;11345-11351.
11. Tenhunen R., Marver H.S., Schmid R. Microsomal heme oxygenase: characterization of the enzyme. J. Biol. Chem. 244:1969;6388-6394.
12. Maines M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 2:1988;2557-2568.
13. Applegate L.A., Luscher P., Tyrrell R.M. Induction of heme oxygenase: a general reponse to oxidant stress in cultured mammalian cells. Cancer Res. 51:1991;974-978.
14. Immenshuh S., Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem. Pharmacol. 60:2000;1121-1128.
15. Wagener F.A., Volk H.D., Willis D., Abraham N.G., Soares M.P., Adema G.J., Figdor C.G. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 55:2003;551-571.
16. Choi B.M., Kim H.J., Oh G.S., Pae H.O., Oh H., Jeong S., Kwon T.O., Kim Y.M., Chung H.T. 1,2,3,4,6-Penta-o-galloyl-beta-D-glucose protects rat neuronal cells (Neuro 2A) from hydrogen peroxide-mediated cell death via the induction of heme oxygenase-1. Neurosci. Lett. 328:2002;185-189.
17. Lee T.S., Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8:2002;240-246.
18. Brouard S., Otterbein L.E., Anrather J., Tobiasch E., Bach F.H., Choi A.M., Soares M.P. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192:2000;1015-1025.
19. Stocker R., McDonagh A.F., Glazer A.N., Ames B.N. Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol. 186:1990;301-309.
20. Duckers H.J., Boehm M., True A.L., Yet S.F., San H., Park J.L., Clinton, Webb R., Lee M.E., Nabel G.J., Nabel E.G. Heme oxygenase-1 protects against vascular constriction and proliferation. Nature Med. 7:2001;693-698.
21. Choi B.M., Pae H.O., Kim Y.M., Chung H.T. Nitric oxide-mediated cytoprotection of hepatocytes from glucose deprivation-induced cytotoxicity: involvement of heme oxygenase-1. Hepatology. 37:2003;810-823.
22. Kroemer G., Dallaporta B., Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:1998;619-642.
23. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic. Biol. Med. 23:1997;783-792.
24. Vile G.F., Basu-Modak S., Waltner C., Tyrrell R.M. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc. Natl. Acad. Sci. USA. 91:1994;2607-2610.
25. Xiong S., She H., Takeuchi H., Han B., Engelhardt J.F., Barton C.H., Zandi E., Giulivi C., Tsukamoto H. Signaling role of intracellular iron in NF-κB activation. J. Biol. Chem. 278:2003;17646-17654.
26. + T cells. Biochem. Biophys. Res. Commun. 306:2003;701-715.
27. Kutty R.K., Maines M.D. Oxidation of heme c derivatives by purified heme oxygenase: evidence for the presence of one molecular species of heme oxygenase in the rat liver. J. Biol. Chem. 257:1982;9944-9952.
28. Kim Y.M., Bergonia H.A., Muller C., Pitt B.R., Watkins W.D., Lancaster J.R. Jr. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J. Biol. Chem. 270:1995;5710-5713.
29. Ke B., Buelow R., Shen X.D., Melinek J., Amersi F., Gao F., Ritter T., Volk H.D., Busuttil R.W., Kupiec-Weglinski J.W. Heme, oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum. Gene Ther. 13:2002;1189-1199.
30. Creighton-Gutteridge M., Tyrrell R.M. A novel iron chelator that does not induce HIF-1 activity. Free Radic. Biol. Med. 33:2002;356-363.
31. Aronis A., Melendez J.A., Golan O., Shilo S., Dicter N., Tirosh O. Potentiation of Fas-mediated apoptosis by attenuated production of mitochondria-derived reactive oxygen species. Cell Death Differ. 10:2003;335-344.
32. Tampo Y., Kotamraju S., Chitambar C.R., Kalivendi S.V., Keszler A., Joseph J., Kalyanaraman B. Oxidative stress-induced iron signaling is responsible for peroxide-dependent oxidation of dichlorodihydrofluorescein in endothelial cells: role of transferrin receptor-dependent iron uptake in apoptosis. Circ. Res. 92:2003;56-63.
33. Rivera-Walsh I., Cvijic M.E., Xiao G., Sun S.C. The NF-κB signaling pathway is not required for Fas ligand gene induction but mediates protection from activation-induced cell death. J. Biol. Chem. 275:2000;25222-25230.
34. Engedal N., Blomhoff H.K. Combined action of ERK and NF-κB mediates the protective effect of phorbol ester on Fas-induced apoptosis in Jurkat cells. J. Biol. Chem. 278:2003;10934-10941.
35. Van Parijs L., Refaeli Y., Abbas A.K., Baltimore D. Autoimmunity as a consequence of retrovirus-mediated expression of c-FLIP in lymphocytes. Immunity. 11:1999;763-770.
36. Micheau O., Lens S., Gaide O., Alevizopoulos K., Tschopp J. NF-κB signals induce the expression of c-FLIP. Mol. Cell. Biol. 21:2001;5299-5305.
37. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle. Cell. 109 (Suppl.):2002;S81-S96.
38. Karin M., Ben-Neriah Y. Phosphorylation, meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:2000;621-663.
39. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 91:1997;243-252.
40. Schreck R., Baeuerle P.A. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB. Methods Enzymol. 234:1994;151-163.
41. Shibanuma M., Kuroki T., Nose K. Inhibition by N-acetyl-L-cysteine of interleukin-6 mRNA induction and activation of NF-κB by tumor necrosis factor alpha in a mouse fibroblastic cell line, Balb/3T3. FEBS Lett. 353:1994;62-66.
42. Staal F.J., Roederer M., Herzenberg L.A., Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 87:1990;9943-9947.
43. Anderson M.T., Staal F.J., Gitler C., Herzenberg L.A., Herzenberg L.A. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proc. Natl. Acad. Sci. USA. 91:1994;11527-11531.
44. Bonizzi G., Piette J., Schoonbroodt S., Greimers R., Havard L., Merville M.P., Bours V. Reactive oxygen intermediate-dependent NF-κB activation by interleukin-1β requires 5-lipoxygenase or NADPH oxidase activity. Mol. Cell. Biol. 19:1999;1950-1960.
45. Kurose I., Saito H., Miura S., Ebinuma H., Higuchi H., Watanabe N., Zeki S., Nakamura T., Takaishi M., Ishii H. CD18/ICAM-1-dependent oxidative NF-κB activation leading to nitric oxide production in rat Kupffer cells cocultured with syngeneic hepatoma cells. J. Clin. Invest. 99:1997;867-878.
46. Chaudhri G., Clark I.A. Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. J. Immunol. 143:1989;1290-1294.
47. Lin M., Rippe R.A., Niemela O., Brittenham G., Tsukamoto H. Role of iron in NF-κB activation and cytokine gene expression by rat hepatic macrophages. Am. J. Physiol. 272:1997;G1355-G1364.
48. Chu Z.L., McKinsey T.A., Liu L., Gentry J.J., Malim M.H., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA. 94:1997;10057-10062.
49. Kreuz S., Siegmund D., Scheurich P., Wajant H. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 21:2001;3964-3973.
50. Lee H.H., Dadgostar H., Cheng Q., Shu J., Cheng G. NF-κB-mediated upregulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA. 96:1999;9136-9141.
51. Chen C., Edelstein L.C., Gelinas C. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20:2000;2687-2695.
52. + lymphocytes. J. Immunol. 165:2000;1743-1754.
53. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15:1999;269-290.
54. +, IL-10-producing T cell population with infectious capacity. J. Immunol. 158:1997;4642-4653.
55. Banz A., Pontoux C., Papiernik M. Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J. Immunol. 169:2002;750-757.
56. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:2000;303-310.
57. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:2002;135-142.
58. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:2003;1057-1061.